Home | Structured Search | Drug Resource
Find: within
Cellulitis and Soft Tissue Infections > Prevention Author: Dennis L. Stevens, PhD, MD; Lawrence J. Eron, MD, FACP
Editorial changes - 2008-10-27
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools

Rationale:

  • Human bite wounds are usually closed fist injuries, which on extension of the fist retract proximally the bacteria inoculated into the bite site. These injuires have a high rate of infection.
  • Cat bites usually result in deep puncture wounds rather than laceration, causing a high rate of infection.
  • Antibiotic prophylaxis reduces the likelihood of infection of certain types of bite wounds.
  • Rabies is fatal once symptoms appear. Prophylaxis with rabies immune globulin and vaccine is highly effective.

Evidence:

  • A Cochrane review found some evidence that antibiotic prophylaxis following bites of the hand can reduce infection, but more research is needed (15).
  • A multicenter prospective study of 50 patients with infected human bites found amoxicillin-clavulanic acid and moxifloxacin to have excellent in-vitro activity against common isolates (16).
  • A prospective study at 18 emergency departments to better define the bacteria causing infections of dog and cat bites concluded that infected dog and cat bites have a complex microbiologic mix that includes pasteurella species but also other organisms that were not previously identified as bite-wound pathogens (17).
  • The Infectious Diseases Society of America has published guidelines for the diagnosis and management of skin and soft-tissue infections (18).

Comments:

  • None.

FAQs
Dennis L. Stevens, PhD, MD has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Lawrence J. Eron, MD, FACP has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2008 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.